Expand DYAI Menu
DYAI MENU

DYAI Latest Press Releases

-- June 15, 2026 --

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption Globe Newswire 7:25 AM

-- May 28, 2026 --

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development Globe Newswire 7:25 AM

-- May 21, 2026 --

Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 Globe Newswire 4:05 PM
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series on Wednesday, May 27 at 12:00 PM ET Globe Newswire 3:45 PM

-- May 20, 2026 --

Sidoti Events, LLC's May Micro-Cap Virtual Conference ACCESS Newswire 7:30 AM

-- May 19, 2026 --

Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference Globe Newswire 9:35 AM

-- May 13, 2026 --

Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress Globe Newswire 4:05 PM

-- April 29, 2026 --

Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 Globe Newswire 4:05 PM

-- March 25, 2026 --

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress Globe Newswire 4:51 PM

-- March 16, 2026 --

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices Globe Newswire 7:20 AM

-- March 13, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing Globe Newswire 8:35 AM

-- March 11, 2026 --

Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 Globe Newswire 4:10 PM

-- March 10, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th Globe Newswire 10:21 AM

-- March 4, 2026 --

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) Globe Newswire 7:20 AM

-- March 2, 2026 --

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone Globe Newswire 7:20 AM

-- February 17, 2026 --

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin Globe Newswire 7:25 AM
Market Data Delayed 15 Minutes